{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:28:11Z","timestamp":1793964491956,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00125-016-4065-6","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T06:06:17Z","timestamp":1471327577000},"page":"2298-2307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":462,"title":["Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21\u00a0years follow-up on the Steno-2 randomised trial"],"prefix":"10.1007","volume":"59","author":[{"given":"Peter","family":"G\u00e6de","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Oellgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bendix","family":"Carstensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Lund-Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Henrik","family":"Parving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluf","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"key":"4065_CR1","doi-asserted-by":"crossref","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB et al (2015) Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 58:429\u2013442","DOI":"10.1007\/s00125-014-3460-0"},{"key":"4065_CR2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi M, Rosengren A, Svensson AM et al (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373:1720\u20131732","journal-title":"N Engl J Med"},{"key":"4065_CR3","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP et al (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372:2387\u20132397","journal-title":"N Engl J Med"},{"key":"4065_CR4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.amjcard.2009.09.025","volume":"105","author":"JC LaRosa","year":"2010","unstructured":"LaRosa JC, Deedwania PC, Shepherd J et al (2010) Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial). Am J Cardiol 105:283\u2013287","journal-title":"Am J Cardiol"},{"key":"4065_CR5","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.jacc.2009.10.005","volume":"54","author":"SA Murphy","year":"2009","unstructured":"Murphy SA, Cannon CP, Wiviott SD, McCabe CH, Braunwald E (2009) Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial. J Am Coll Cardiol 54:2358\u20132362","journal-title":"J Am Coll Cardiol"},{"key":"4065_CR6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa065994","volume":"357","author":"I Ford","year":"2007","unstructured":"Ford I, Murray H, Packard CJ et al (2007) Long-term follow-up of the West of Scotland coronary prevention study. N Engl J Med 357:1477\u20131486","journal-title":"N Engl J Med"},{"key":"4065_CR7","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.jacc.2009.09.021","volume":"54","author":"SE Nissen","year":"2009","unstructured":"Nissen SE (2009) Cardiovascular outcomes in randomized trials: should time to first event for \u201chard\u201d end points remain the standard approach? J Am Coll Cardiol 54:2363\u20132365","journal-title":"J Am Coll Cardiol"},{"key":"4065_CR8","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jacc.2009.08.035","volume":"54","author":"MJ Tikkanen","year":"2009","unstructured":"Tikkanen MJ, Szarek M, Fayyad R et al (2009) Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (incremental decrease in end points through aggressive lipid lowering) trial. J Am Coll Cardiol 54:2353\u20132357","journal-title":"J Am Coll Cardiol"},{"key":"4065_CR9","doi-asserted-by":"crossref","unstructured":"Faerch K, Carstensen B, Almdal TP, Jorgensen ME (2014) Improved survival among patients with complicated type 2 diabetes in Denmark: a prospective study (2002\u20132010). J Clin Endocrinol Metab 99:E642\u2013E646","DOI":"10.1210\/jc.2013-3210"},{"key":"4065_CR10","doi-asserted-by":"crossref","unstructured":"Gregg EW, Li Y, Wang J et al (2014) Changes in diabetes-related complications in the United States, 1990\u20132010. N Engl J Med 370:1514\u20131523","DOI":"10.1056\/NEJMoa1310799"},{"key":"4065_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","volume":"353","author":"P G\u00e6de","year":"1999","unstructured":"G\u00e6de P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the steno type 2 randomised study. Lancet 353:617\u2013622","journal-title":"Lancet"},{"key":"4065_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P G\u00e6de","year":"2003","unstructured":"G\u00e6de P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383\u2013393","journal-title":"N Engl J Med"},{"key":"4065_CR13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P G\u00e6de","year":"2008","unstructured":"G\u00e6de P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580\u2013591","journal-title":"N Engl J Med"},{"key":"4065_CR14","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryden","year":"2013","unstructured":"Ryden L, Grant PJ, Anker SD et al (2013) ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34:3035\u20133087","journal-title":"Eur Heart J"},{"issue":"Suppl","key":"4065_CR15","first-page":"S49-57","volume":"38","author":"American Diabetes A","year":"2015","unstructured":"American Diabetes A (2015) (8) Cardiovascular disease and risk management. Diabetes Care 38(Suppl):S49-57","journal-title":"Diabetes Care"},{"key":"4065_CR16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge E, Sandegaard JL, Rebolj M (2011) The Danish National Patient Register. Scand J Public Health 39:30\u201333","journal-title":"Scand J Public Health"},{"key":"4065_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB (2011) The Danish Civil Registration System. Scand J Public Health 39:22\u201325","journal-title":"Scand J Public Health"},{"key":"4065_CR18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","volume":"364","author":"HC Gerstein","year":"2011","unstructured":"Gerstein HC, Miller ME, Genuth S et al (2011) Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 364:818\u2013828","journal-title":"N Engl J Med"},{"key":"4065_CR19","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","volume":"371","author":"S Zoungas","year":"2014","unstructured":"Zoungas S, Chalmers J, Neal B et al (2014) Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 371:1392\u20131406","journal-title":"N Engl J Med"},{"key":"4065_CR20","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577\u20131589","journal-title":"N Engl J Med"},{"key":"4065_CR21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR (2008) Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 359:1565\u20131576","journal-title":"N Engl J Med"},{"key":"4065_CR22","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/dc13-0149","volume":"36","author":"L Shi","year":"2013","unstructured":"Shi L, Ye X, Lu M et al (2013) Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes. Diabetes Care 36:3297\u20133304","journal-title":"Diabetes Care"},{"key":"4065_CR23","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2337\/dc09-0959","volume":"32","author":"S Zoungas","year":"2009","unstructured":"Zoungas S, de Galan BE, Ninomiya T et al (2009) Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care 32:2068\u20132074","journal-title":"Diabetes Care"},{"key":"4065_CR24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2015.06.019","volume":"66","author":"V Bittner","year":"2015","unstructured":"Bittner V, Bertolet M, Barraza Felix R et al (2015) Comprehensive cardiovascular risk factor control improves survival: the BARI 2D trial. J Am Coll Cardiol 66:765\u2013773","journal-title":"J Am Coll Cardiol"},{"key":"4065_CR25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/dc13-2116","volume":"37","author":"JM Lachin","year":"2014","unstructured":"Lachin JM, Orchard TJ, Nathan DM, Group DER (2014) Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study. Diabetes Care 37:39\u201343","journal-title":"Diabetes Care"},{"key":"4065_CR26","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1414266","volume":"372","author":"RA Hayward","year":"2015","unstructured":"Hayward RA, Reaven PD, Wiitala WL et al (2015) Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med 372:2197\u20132206","journal-title":"N Engl J Med"},{"key":"4065_CR27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc15-2283","volume":"39","author":"Advance Study Group","year":"2016","unstructured":"Advance Study Group (2016) Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes. Diabetes Care 39:701\u2013708","journal-title":"Diabetes Care"},{"key":"4065_CR28","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","volume":"374","author":"S Yusuf","year":"2016","unstructured":"Yusuf S, Lonn E, Pais P et al (2016) Blood-pressure and cholesterol lowering in persons without cardiovascular disease. N Engl J Med 374:2032\u20132043","journal-title":"N Engl J Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-016-4065-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4065-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4065-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T06:56:56Z","timestamp":1499756216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-016-4065-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["4065"],"URL":"https:\/\/doi.org\/10.1007\/s00125-016-4065-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726647941.793524615","asserted-by":"object"}]},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,16]]}}}